Mangoceuticals (MGRX) Change in Accured Expenses (2023 - 2026)
Mangoceuticals recorded quarterly Change in Accured Expenses of -$9191.0 in Q1 2026, up 90.64% quarter-over-quarter from -$98169.0 in Q4 2025, and down 102.7% year-over-year from $340678.0 in Q1 2025.
Mangoceuticals' Change in Accured Expenses history runs 4 years deep, the most recent figure standing at -$9191.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 102.7% year-over-year to -$9191.0; the TTM figure through Mar 2026 stood at -$294200.0 (down 205.57% YoY), while the FY2025 annual figure was $55669.0, up 306.18% from the prior year.
- Change in Accured Expenses came in at -$9191.0 for Q1 2026 at Mangoceuticals, up from -$98169.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $542885.0 in Q2 2024 to a low of -$593754.0 in Q4 2024.
- A 4-year average of $9736.0 and a median of -$9191.0 in 2026 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 873.37% in 2025 and fell as far as 2385.46% in 2025.
- Mangoceuticals' Change in Accured Expenses stood at $51706.0 in 2023, then tumbled by 1248.33% to -$593754.0 in 2024, then soared by 83.47% to -$98169.0 in 2025, then jumped by 90.64% to -$9191.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$9191.0, -$98169.0, and -$276656.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 6.24 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -20.60 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -35.25 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -9.67 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -6.14 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 49.11 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -10.77 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | -9,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,191.00 |
| Mar 31, 2026 | -9,191.00 |
| Dec 31, 2025 | -370,196.00 |
| Dec 31, 2025 | -370,196.00 |
| Sep 30, 2025 | -276,656.00 |
| Sep 30, 2025 | -276,656.00 |
| Jun 30, 2025 | 89,816.00 |
| Jun 30, 2025 | 89,816.00 |
| Mar 31, 2025 | 340,678.00 |
| Mar 31, 2025 | 340,678.00 |
| Dec 31, 2024 | 721,736.00 |
| Dec 31, 2024 | 721,736.00 |
| Sep 30, 2024 | -602,885.00 |
| Sep 30, 2024 | -602,885.00 |
| Jun 30, 2024 | -297,295.00 |
| Jun 30, 2024 | -297,295.00 |
| Mar 31, 2024 | 875,180.00 |
| Mar 31, 2024 | 875,180.00 |
| Dec 31, 2023 | 51,706.00 |
| Dec 31, 2023 | 51,706.00 |
| Sep 30, 2023 | -41,146.00 |
| Sep 30, 2023 | -41,146.00 |
| Jun 30, 2023 | 110,246.00 |
| Jun 30, 2023 | 110,246.00 |
| Mar 31, 2023 | -13,716.00 |
| Mar 31, 2023 | -13,716.00 |